The Metformin Active Surveillance Trial (MAST) Study

Clinical trial NCT01864096 · UNKNOWN

Trial details

NCT number: NCT01864096
Sponsor: University Health Network, Toronto
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2013-10-01
Primary completion: 2024-02-16
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.